Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Comparison of Outcomes After Related and Unrelated Hematopoietic Cell Transplantation in Adults with Myelodysplastic Syndromes: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

Wael Saber, MD, MS, Corey Cutler, MD, MPH, FRCPC, Ryotaro Nakamura, MD, Mei-Jie Zhang, PhD, Ehab Atallah, MD, J. Douglas Rizzo, MD, MS, Richard T. Maziarz, MD, Jorge E. Cortes, MD, Matt Kalaycio, MD, Mary M. Horowitz, MD, MS

Blood (2012) 120 (21): 355.

https://doi.org/10.1182/blood.V120.21.355.355

Published: 2012

Journal Articles

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

Michael J Eckrich, MD, MPH, Jennifer Le-Rademacher, PhD, J. Douglas Rizzo, MD, MS, K. Scott Baker, MD, MS, Deepika Bhatla, MD, David K. Buchbinder, M.D., M.S.H.S., Kenneth R. Cooke, MD, Reggie Duerst, MD, Andrew Gilman, MD, Haydar Frangoul, MD, Neena Kapoor, MD, Nancy A. Kernan, MD, Michael Verneris, MD, Mary Eapen, MBBS

Blood (2012) 120 (21): 762.

https://doi.org/10.1182/blood.V120.21.762.762

Published: 2012

Journal Articles

The Value of the Hematologist: Appropriate Use of Diagnostic Endoscopy in Microcytic and Normocytic Anemias (MNA)

Vincent Picozzi, MD, MMM, Jeanae Releford, BS, Margaret Faure, BS, Daniel Eastwood, MS, J. Douglas Rizzo, MD, MS

Blood (2011) 118 (21): 342.

https://doi.org/10.1182/blood.V118.21.342.342

Published: 2011

Journal Articles

Graft-Versus-Host Disease (GVHD) Induced Graft-Versus-Leukemia (GVL) Effect: More Impact on Later Relapse and Disease-Free Survival Following Reduced Intensity Conditioning

Daniel J. Weisdorf, MD, Mei-Jie Zhang, PhD, Mukta Arora, MD, J. Douglas Rizzo, MD MS, Mary M. Horowitz, MD, Mary Eapen, MBBS

Blood (2011) 118 (21): 1014.

https://doi.org/10.1182/blood.V118.21.1014.1014

Published: 2011

Journal Articles

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Brian McClune, DO, Tanya L. Pedersen, MPH, Kwang W Ahn, PhD, Erica D Warlick, MD, Joseph Pidala, MD, MS, Edmund K Waller, MD PhD, J. Douglas Rizzo, MD MS, Mitchell S. Cairo, MD, Ann Woolfrey, MD, Andrew Artz, MD MS, Hillard M. Lazarus, MD FACP, Daniel J. Weisdorf, MD

Blood (2011) 118 (21): 1015.

https://doi.org/10.1182/blood.V118.21.1015.1015

Published: 2011

Journal Articles

Significant Improvement In Overall Survival In Patients Who Underwent Autologous Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005

Philip L. McCarthy, MD, Theresa Hahn, PhD, Anna Hassebroek, MPH, John P. Klein, Ph.D., J. Douglas Rizzo, MD, MS, Susan Parsons, MD, MRP, Steven Joffe, MD, MPH, Navneet S. Majhail, MD, MS

Blood (2010) 116 (21): 2389.

https://doi.org/10.1182/blood.V116.21.2389.2389

Published: 2010

Journal Articles

Relationship of Race/Ethnicity and Survival After Single Umbilical Cord Blood Transplantation

Karen K. Ballen, MD, John P. Klein, Ph.D., Tanya L. Pedersen, MPH, Joanne Kurtzberg, MD, Hillard M. Lazarus, MD, FACP, Charles F. LeMaistre, MD, Paulette Mehta, M.D, MPH, Jeanne Palmer, MD, Michelle Setterholm, John R. Wingard, MD, Steven Joffe, MD, MPH, Susan K. Parsons, MD, MRP, Galen E. Switzer, PhD, Stephanie J. Lee, MD, MPH, J. Douglas Rizzo, MD, MS, Navneet S. Majhail, MD, MS, for the Health Policy Working Committee of the CIBMTR

Blood (2010) 116 (21): 224.

https://doi.org/10.1182/blood.V116.21.224.224

Published: 2010

Journal Articles

Spleen Status and Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation (HCT).

Blood (2010) 116 (21): 3486.

https://doi.org/10.1182/blood.V116.21.3486.3486

Published: 2010

Journal Articles

Significant Improvement In Day 100 and 1-Year Overall Survival In Patients Who Underwent Myeloablative Allogeneic Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005

Theresa Hahn, PhD, Philip L. McCarthy, MD, Anna Hassebroek, MPH, John P. Klein, PhD, J. Douglas Rizzo, MD, MS, Susan Parsons, MD, MRP, Steven Joffe, MD, MPH, Navneet S. Majhail, MD, MS

Blood (2010) 116 (21): 3509.

https://doi.org/10.1182/blood.V116.21.3509.3509

Published: 2010

Journal Articles

Tandem Autologous Stem Cell Transplants (auto-auto) with or without Maintenance Therapy Versus Single Autologous Transplant Followed by HLA-Matched Sibling Non- Myeloablative Allogeneic Stem Cell Transplant (auto-allo) for Patients (pts) with High Risk (HR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0102 Trial

Blood (2010) 116 (21): 526.

https://doi.org/10.1182/blood.V116.21.526.526

Published: 2010

Journal Articles

Reducing the Risk for Transplant Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?.

John Horan, MD, MPH, Brent R. Logan, PhD, Manza-A. Agovi, MPH, Hillard M Lazarus, MD, Andrea Bacigalupo, MD, Karen Ballen, Rodrigo Martino, Mark B. Juckett, MD, Hanna J. Khoury, MD, Christopher Bredeson, MD, Vikas Gupta, Franklin O. Smith, MD, Gregory Hale, Matthew Carabasi, MD, Philip L. McCarthy, MD, J. Douglas Rizzo, MD, MS, Marcelo C. Pasquini, MD

Blood (2009) 114 (22): 649.

https://doi.org/10.1182/blood.V114.22.649.649

Published: 2009

Journal Articles

Obesity Adversely Affects Survival of Pediatric Patients with Severe Aplastic Anemia After Hematopoietic Cell Transplantation.

Collin C. Barker, MD, MSc., Manza- A Agovi, MPH, Brent Logan, PhD, Vikas Gupta, MD, MRCP, FRCPath, Hillard M. Lazarus, MD, Karen K Ballen, MD, Gregory A. Hale, MD, Haydar Frangoul, MD, J. Douglas Rizzo, MD, MS, Marcelo C. Pasquini, MD, MS

Blood (2009) 114 (22): 652.

https://doi.org/10.1182/blood.V114.22.652.652

Published: 2009

Journal Articles

Long-Term Survival and Late Relapse in 5-Year Survivors of Allogeneic Hematopoietic-Cell Transplantation (HCT) for Chronic Myeloid Leukemia (CML) in First Chronic Phase.

John M. Goldman, DM, FRCP, FRCPath, Navneet S. Majhail, MD, MS, John P. Klein, PhD, Zhiwei Wang, MS, Kathleen A. Sobocinski, MS, Mukta Arora, MD, Mary M. Horowitz, MD, MS, J. Douglas Rizzo, MD, MS

Blood (2009) 114 (22): 3321.

https://doi.org/10.1182/blood.V114.22.3321.3321

Published: 2009

Journal Articles

Long-Term Survival and Late Deaths in 2-Year Survivors of Myeloablative Allogeneic Hematopoietic-Cell Transplantation for Hematologic Disorders.

John R. Wingard, MD, Navneet S. Majhail, MD, MS, Ruta Bajorunaite, PhD, Zhiwei Wang, MS, Kathleen A. Sobocinski, MS, David Jacobsohn, MD, Mohamed L Sorror, J. Douglas Rizzo, MD, MS, Brian J. Bolwell, Gérard Socié, MD

Blood (2009) 114 (22): 520.

https://doi.org/10.1182/blood.V114.22.520.520

Published: 2009

Journal Articles

Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults

Willis H. Navarro, MD, Manza-A Agovi, MPH, Brent Logan, PhD, Andrea Bacigalupo, MD, Karen K Ballen, MD, Brian J. Bolwell, MD, Haydar Frangoul, MD, Vikas Gupta, MD, MRCP, MRCPath, Theresa Hahn, PhD, Mark Juckett, MD, Hillard M. Lazarus, MD, Mark R. Litzow, MD, Jane Liesveld, MD, Jan Moreb, MD, David Marks, MD, PhD, Philip L. McCarthy, MD, J. Douglas Rizzo, MD, MS

Blood (2008) 112 (11): 51.

https://doi.org/10.1182/blood.V112.11.51.51

Published: 2008

Journal Articles

Second Unrelated Donor (URD) Transplant as a Rescue Strategy for 122 Patients with Primary Non Engraftment: Results from the CIBMTR

Jeffrey R. Schriber, MD, Manza- A Agovi, MPH, Karen K Ballen, MD, Andrea Bacigalupo, MD, Gregory A. Hale, MD, Vikas Gupta, MD, MRCP, MRCPath, Hillard M. Lazarus, MD, Mark R. Litzow, MD, David I. Marks, MD, Roger H. Giller, MD, Richard T. Maziarz, MD, Martin Bornhauser, MD, Luis M. Isola, MD, Christopher Bredeson, MD, J. Douglas Rizzo, MD, MS

Blood (2008) 112 (11): 794.

https://doi.org/10.1182/blood.V112.11.794.794

Published: 2008

Journal Articles

Pre-Transplant Rituximab Therapy Is Associated with Improved Progression-Free and Overall Survival in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma (DLBCL).

Timothy S. Fenske, MD, Parameswaran Hari, MD, Jeanette Carreras, MPH, Mei-Jie Zhang, PhD, Rammurti Kamble, MD, J. Douglas Rizzo, MD, MS, Koen van Besien, MD, Hillard M. Lazarus, MD, Julie M. Vose, MD

Blood (2007) 110 (11): 19.

https://doi.org/10.1182/blood.V110.11.19.19

Published: 2007

Journal Articles

Superior Survival after Autologous vs. Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Diffuse Large B-Cell Lymphoma (DLBCL) Not Explained by Differences in Chemosensitivity.

Brandon Hayes-Lattin, MD, Jeanette Carreras, MPH, Mei-Jie Zhang, PhD, Koen van Besien, MD, Julie M. Vose, MD, Hillard M. Lazarus, MD, J. Douglas Rizzo, MD, MS, Parameswaran Hari, MD

Blood (2006) 108 (11): 3021.

https://doi.org/10.1182/blood.V108.11.3021.3021

Published: 2006

NARROW

Comparison of Outcomes After Related and Unrelated Hematopoietic Cell Transplantation in Adults with Myelodysplastic Syndromes: A Report From the Center for International Blood and Marrow Transplant Research (CIBMTR)

The Effect of Transplant Center Characteristics On Survival After Pediatric Hematopoietic Cell Transplantation

The Value of the Hematologist: Appropriate Use of Diagnostic Endoscopy in Microcytic and Normocytic Anemias (MNA)

Graft-Versus-Host Disease (GVHD) Induced Graft-Versus-Leukemia (GVL) Effect: More Impact on Later Relapse and Disease-Free Survival Following Reduced Intensity Conditioning

Reduced Intensity or Non-Ablative Hematopoietic Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma (NHL): Encouraging Survival for Patients ≥55 Years

Significant Improvement In Overall Survival In Patients Who Underwent Autologous Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005

Relationship of Race/Ethnicity and Survival After Single Umbilical Cord Blood Transplantation

Spleen Status and Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation (HCT).

Significant Improvement In Day 100 and 1-Year Overall Survival In Patients Who Underwent Myeloablative Allogeneic Hematopoietic Cell Transplant In the US or Canada Between 1994 and 2005

Reducing the Risk for Transplant Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?.

Obesity Adversely Affects Survival of Pediatric Patients with Severe Aplastic Anemia After Hematopoietic Cell Transplantation.

Long-Term Survival and Late Relapse in 5-Year Survivors of Allogeneic Hematopoietic-Cell Transplantation (HCT) for Chronic Myeloid Leukemia (CML) in First Chronic Phase.

Long-Term Survival and Late Deaths in 2-Year Survivors of Myeloablative Allogeneic Hematopoietic-Cell Transplantation for Hematologic Disorders.

Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) in Adults

Second Unrelated Donor (URD) Transplant as a Rescue Strategy for 122 Patients with Primary Non Engraftment: Results from the CIBMTR

Pre-Transplant Rituximab Therapy Is Associated with Improved Progression-Free and Overall Survival in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma (DLBCL).

Superior Survival after Autologous vs. Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Diffuse Large B-Cell Lymphoma (DLBCL) Not Explained by Differences in Chemosensitivity.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only